Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-07

Clinical Trial Update: Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating a fixed-dose combination pill of losartan potassium and hydrochlorothiazide to improve medication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Losartan Potassium (Losartan potassium)

Snippet

Sponsor: Kyushu University | Conditions: Hypertension | Phase 3 | Status: COMPLETED